Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Cannabis Degrees: Industry at Crossroads on Making Hiring Decisions

One of the trends in the cannabis sector is the growing number of higher education institutions offering cannabis courses at all levels, including degree programs. This trend comes at a time when another trend — doing away with college degree qualifications — is sweeping through the human resources field. So should or shouldn’t marijuana companies hire people with college degrees?

For starters, those arguing against college degrees in the cannabis industry or anywhere else say that those degrees create a widening divide that locks out a huge majority of people from the lucrative job opportunities available. Statistics show that a little more than one-half of all Americans don’t have college degrees, so demanding a college degree as a job requirement worsens the inequalities in the society. Additionally, marijuana industry veterans assert that the industry was built by innovative, risk-taking people who didn’t have any college degrees, so they see no reason why the college degrees are making their appearance now that the industry is firmly on a trajectory of growth.

Removing or not considering college degrees when hiring also widens the options since more people will express interest in an available position. This is particularly necessary at this time when there is a general labor shortage in most industries.

However, the side in support of college degrees has its own strong arguments. For example, they say that there are specific roles within the industry that require personnel with college degrees. For example, the industry needs attorneys who have specialized in cannabis law Additionally, many in the industry see college degrees and other such qualifications as a way to increase access to jobs in this growing sector. This is because the degree provides the credentials that one needs to get a job on merit rather than relying on the “old-boy” network and other such relationships while looking for a job.

Esai Miera, founder of Colorado Cannabis Education, belongs to this school of thought that sees marijuana education as a ticket to a job even if you don’t personally have a connection to someone within the industry. He adds that cannabis education is needed to move the industry forward since it has reached a point where specialized skills are now needed if any company is to stand out and beat the stiff competition.

As things stand, it isn’t easy to tip the degree-or-no-degree debate in one direction or other. There are so many nuances to this that each company, such as American Cannabis Partners, may have to handle this matter on a case-by-case basis.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company currently developing a pipeline of cannabinoid-based pharmaceutical drug candidates to treat several diseases with high, unmet medical needs. The company’s focus is on rare cannabinoids, many of which are not yet available in commercial-size quantities, such as cannabidivarin – (“CBDV”) and tetrahydrocannabivarin – (“THCV”). “The acquisition of BayMedica in October 2021 has provided an advantage for InMed in the rare cannabinoid biosynthesis industry,” reads a recent article discussing the company. “BayMedica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector and now operates as a subsidiary of InMed. BayMedica is comprised of a team of key scientists and professionals from large-scale producers, which gives InMed the unique opportunity to use the technology to scale up rare cannabinoid synthesis production… In a January news release, Shane Johnson, SVP and general manager of BayMedica, said the company was delivering on its objective to launch additional rare cannabinoids in early 2022 in response to inbound demand. ‘By midyear, we expect to have at least four rare cannabinoids available for the health and wellness markets, positioning us as a leading large-scale supplier of high-quality rare cannabinoids in these sectors,’ Johnson explained.”

To view the full article, visit https://cnw.fm/q1OpK

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development, manufacturing and commercialization of rare cannabinoids. Together with its subsidiary BayMedica LLC, the company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. InMed is also a clinical-stage company developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.InMedPharma.com and www.BayMedica.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://cnw.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Update on Proposed Acquisition of Diagnostic Lab Corporation

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, today issued an update on its previously announced execution of a memorandum of understanding (“MOU”) with Englewood Cliffs, New Jersey-based Diagnostic Lab Corporation (“DLC”), a diversified food and agriculture safety company, concerning Grapefruit’s acquisition of DLC. According to the update, the company and DLC (the “parties”) have been in regular discussions since the execution of the MOU regarding the terms and timing of the proposed acquisition. The parties have developed a plan, under which Grapefruit will acquire substantially all of the assets of DLC and obtain financing of $12.5 million, $7 million of which has already been committed, to build out its “Mothership” state of the art cultivation and laboratory center. “As previously announced, these will be the next steps in Grapefruit’s evolution into a medical science-based cannabiotech company, which will develop and obtain regulatory approval for an ever-expanding line of proprietary Hourglass technology-based cannabis products. The build out of the ‘Mothership’ cultivation and lab facility at the Coachillin Park will guarantee a reliable source of reasonably priced pharma quality cannabis flowers to provide the base for non-hemp Hourglass products and for distribution in both the U.S. and Canada, when appropriate. Obtaining the 510K approval for the Hourglass technology will facilitate its rapid market acceptance,” said Bradley J. Yourist, Grapefruit’s CEO and co-founder. “Our lab acquisition program will provide rapid revenue growth and expand the company’s cannabis industry expertise. The parties expect to execute and announce a binding letter of intent before the end of May 2022.”

To view the full press release, visit https://cnw.fm/5n26V

About Grapefruit USA Inc.

Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit’s extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Road, approximately 14 miles north of downtown Palm Springs. For more information about the company and its operations, visit www.GrapefruitBlvd.com.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

BizCann Expo Visits Medellin, Gathering Local Cannabis Entrepreneurs, Business Owners, and Industry Leaders

BizCann Expo, a leading business and networking event, is happy to announce their next event in Medellin, Colombia! Taking place this May 21-22, 2022 at the city’s Plaza Mayor, this event is open to cannabis professionals, startups, entrepreneurs, and enthusiasts!

Featuring the industry’s leading figures and service providers, participants can enjoy networking and building relationships with like-minded professionals. Exhibitors can showcase their ideas and skills to an enthusiastic audience, and connect with eager investors.

A massive forum for collaborations, young entrepreneurs seeking guidance can network with tons of industry leaders. New businesses looking for fresh avenues and useful business tips, as well as more established brands, can all leverage this forum to communicate with potential clients and investors.

Attendees can leverage the platform to gain new business ideas, and understand the most recent market trends. Plus, this is also a great opportunity to get ahead and learn about the latest technologies as well as industry-wide updates.

BizCann Expo prides itself in delivering the ultimate and most complete show possible for anyone seeking cannabis industry-tailored services: inventory, legal advisory, marketing, retail, tools, as well as consultancy from some of the top cannabis panel experts, are just some of the resources available.

Immerse yourself in engaging discussions, keynotes, and workshops that will guide you through all aspects of the industry. Some of the topics discussed during this edition of BizCann Expo include the future of cannabis in Medellin, legislation & licensing, among others.

To learn more, or to purchase your tickets, please visit bizcannexpo.com.

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lift&Co’s Expo 2022 to Host the Canadian Cannabis Industry’s Leading Luminaries

Lift&Co, widely recognized as the hub for the Canadian cannabis industry, is gearing up to host Lift&Co. Expo Toronto on May 12-15, 2022 (Exhibits Open May 13-15). Set to be held at the Metro Toronto Convention Centre, Canada’s premiere industry event for cannabis professionals, investors, consumers and the media will welcome over 150 expert speakers, upwards of 150 exhibitors and thousands of attendees over the course of four days.

Lift&Co. Expo Toronto 2022 will be divided into multiple segments. First, the Lift Cannabis Business Conference (“LCBC”) on May 12 brings an exclusive, full-day conference gathering together Canada’s top business leaders, subject matter experts, innovators and regulators from across the cannabis industry. The following two days, May 13 and 14, see the opening of the Lift&Co. Expo trade show, open exclusively to members of the industry on these dedicated days. Featuring networking opportunities, discoveries and can’t miss-programming, Lift&Co. Expo Industry Days will enable attendees to kickstart relationships, create opportunities and fuel collaborations with some of the most cutting-edge companies within the cannabis industry. In a unique twist to its regular schedule, this year’s Lift&Co. Expo will also play host to the CannaVest North Investment Forum on May 13 and 14, a unique event connecting cannabis companies with accredited investors, while providing education from a financial perspective.

The closing day of this year’s Lift&Co. Expo will be dedicated to patients, consumers and enthusiasts. Over 150+ exhibitors from Canada and around the world will highlight a wide array of products, complemented by programming surrounding new insights and ideas in the cannabis space. Throughout the event, attendees will be given a chance to learn about a variety of topics, including ‘How to Master Supply, Demand and Business Growth in a Quickly Changing Market’ delivered by Deloitte’s Nico Hache and Jawad Skieneh, Master Grower at Greenway Greenhouse Cannabis Corp; ‘The Next Big New Product Category – and What They Might Be?’ by HCD Research’s Allison Gutkowski; ‘Techniques for Better Sowing, Growing and Harvesting to Remain Competitive’ from Atiyyah Ferouz, Founder and CEO of AgCann Consultancy and Av Singh, PhD, PAg, Cannabis Cultivation Advisor; and ‘The Future for Edible Products’ by Nextleaf Solutions CEO, Paul Pedersen, among many others.

Renowned for its uniquely irresistible experience that keeps thousands of cannabis industry movers, shakers and trailblazers buzzing, this year’s Lift&Co Expo will have something fun around every corner, including prizes, 420 receptions, photo activations and entertainment. All told, upcoming Lift&Co. Expo Toronto 2022 promises to be a truly unmissable event.

For additional information about Lift&Co. Expo 2022, including ticket sales, visit https://liftexpo.ca/.

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Advanced Container Technologies Inc. (ACTX) Offers New Tech with GrowPod Automated, Indoor Micro-Farms

Innovators in food supply field have been developing new technologies such as indoor farms
These game-changing micro-farms can be built anywhere
ACTX is the exclusive distributor of GrowPods in the United States

With global supply chain issues grabbing headlines and impacting almost every industry, potential solutions in any sector are certain to capture attention. Hence Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, is definitely seeing interest in the environmentally controlled micro-farms that allow cultivation of ultraclean crops year-round.

“Land preservation and regenerative organic agriculture practices are critical to solving food insecurity and combating climate change,” reported a recent GreenBiz article titled, “How Vertical and Indoor Farming Can Supplement the Food Supply Chain” (https://cnw.fm/PPtvO). The article pointed out, however, that land is limited. “That’s why innovators in the field have been developing new technologies such as indoor and vertical farms designed to supplement outdoor farming.

“Indoor farming allows for certain foods to be grown hydroponically in a closed-loop environment year-round,” stated the article. The article went on to quote John Church, cohead of Food & Beverage for HSBC USA, who observed that “these systems often recirculate water, which can be more efficient than how water is used for other types of crops. Light and temperature can also be controlled, and since there is no exposure to pests, no chemistry is needed.”

However, one of the most significant benefits of these farms, the article noted, “is that they can be built anywhere. That means food such as leafy greens can be grown closer to population centers. Because it travels fewer miles to the plate, the taste and texture of the output from indoor farms is often better than conventionally grown produce.

“While indoor and vertical farming will not feed the world, Church believes it can supplement the supply chain,” the article states. “One leader in indoor farming, for instance, recently began construction of a research center in Abu Dhabi, UAE. ‘This is the perfect spot for a vertical indoor farm,’ he explained. Due to its arid environment, the conditions are not suitable for outdoor growing, so the country has historically imported its produce. Recently the UAE’s government publicly stated it wants to become more sustainable — and this solution will go a long way in helping it achieve that.

These are only a few of the advantages that GrowPods, which are self-contained, automated, indoor micro-farms, offer users. These innovative containerized growing systems are designed with functionality and ease of use in mind. The pods are configured to optimize plant growth while minimizing labor; setup is quick and simple, no pesticides are needed, and the containers produce harvests all year long.

Advanced Container Technologies is in the business of selling and distributing GrowPods, along with related equipment and supplies. Additionally, the company designs and sells patented, proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — NJ Legislators File Bills Seeking to Prevent Off-Duty Cannabis Use by Police

We reported about the controversy that had arisen when the New Jersey attorney general penned a memo clarifying that, under existing law, police officers aren’t barred from consuming cannabis while off duty. As a result of that memo, several bills have been filed in order to empower employers, including law enforcement agencies, to ban the use of marijuana by people occupying safety-sensitive jobs, including those in law enforcement.

One of the three measures that have been filed aims at giving law enforcement agencies the authority to act against the police for consuming marijuana even while off duty. This particular measure was filed by Rep. Louis Greenwald, a Democrat. His bill will also give law enforcement agencies leeway to undertake random testing for drugs and also turn down any applicants who have a history of using cannabis in compliance with the laws of the state.

At the moment, people serving in law enforcement agencies cannot be penalized for consuming marijuana as long as they don’t show up for work while impaired. This situation is concerning to the governor and other influential lawmakers who feel that police officers and other law enforcement personnel shouldn’t be allowed to consume cannabis.

While the bill introduced by Greenwald is looking at imposing cannabis consumption restrictions on the police, two other bills have a wider scope and seek to bring amendments that curtail cannabis consumption rules that started being implemented last month. For example, one of those other bills wants to bar first responders from consuming recreational marijuana even if the substance is legally available within the state.

The third bill, whose full text isn’t readily available yet, is intended to grant employers permission to restrict certain employees from consuming marijuana products. Without the full text of this draft law, it isn’t easy to decipher which particular categories of employers the proposed law is targeting with this permission to restrict the lawful use of marijuana.

If you think that these bills are unpopular given that recreational marijuana sales have just been launched, think again. There is widespread concern that people who bear arms to protect and serve the community wouldn’t be in contravention of any laws if they consumed cannabis products outside their work hours. As a result of this concern, several local authorities, including members of the city council of Newark, have taken steps to unilaterally ban cannabis use by the police. Other mayors and councils are also vowing to issue their own orders restricting off-duty use by police officers in their jurisdictions.

As legalization spreads to more states across the country and major sector players such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) establish their foothold, the regulatory kinks like those raising dust in New Jersey will be resolved and the industry will keep growing.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Assessing Impaired Driving Is Evolving as Cannabis Legalization Spreads

When the current wave of marijuana legalization hadn’t fully taken root around the country, concerns about impaired driving mainly focused on alcohol. Today, impaired driving can be due to alcohol, cannabis and, in some few cases, medications.

For a police officer looking for impaired drivers, there is a growing challenge to distinguish cannabis impairment from impairment caused by alcohol consumption. This is because there is no agreement about how much THC, the cannabis compound responsible for making users high, is sufficient to cause a driver to be impaired. Additionally, impaired drivers exhibit the same signs, such as swerving while driving, delayed reactions while at traffic intersections, driving too slowly or too fast, and so on.

As a result, law enforcement agencies in different jurisdictions are having to tweak their protocols and procedures in order to take action against those suspected to be driving under the influence of cannabis (DUIC). Captain Rick Bancroft, who works in the sheriff’s department in Monroe County, New York, defines drugged drivers as drivers who are impaired by a substance that isn’t alcohol. Such a person drives in a way that is unsafe to themselves and other road users, which is why impaired driving is of concern to law enforcement.

Since there is no acceptable test to rule out or confirm cannabis impairment, Bancroft says that officers now have to rely on the normal sobriety tests that they have been conducting and then add the special measures drug-recognition professionals recommend when deciding whether someone is driving under the influence of marijuana or not.

Some police departments, such as the Rochester PD, have a 12-step process to help in identifying people who are suspected to be impaired by cannabis. For example, an officer may use a breathalyzer to find out whether a driver exhibiting the signs of impaired driving has a blood alcohol level exceeding the legal limit.

Once alcohol impairment is ruled out, the officer may look at the taste buds at the back of the mouth to see if they look dark and are swollen. This is often a sign that someone has consumed cannabis a short while before. The pupils will also be dilated while the eyes will be bloodshot.

For people who show signs of cannabis impairment, an ultraviolet light is shone on the tongue and if red patches show on the tongue, THC consumption is strongly suspected. The screening process continues until as many of the 12 steps as possible have been exhausted. An arrest is then made, and the struggle to prove cannabis impairment in court begins.

As the consumption of marijuana becomes more mainstream, opportunities may arise for companies such as Advanced Container Technologies Inc. (OTC: ACTX), which don’t deal in marijuana directly but rather meet the needs of people in the “plant-touching” line of business. These companies have every reason to support efforts to keep impaired drivers off the road.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-Nicotine Pouch Performance to Be Compared to That of Leading Brands

Lexaria Bioscience Corp. (NASDAQ: LEXX) is expected to begin dosing for the NIC-H22-1 human study this summer. “NIC-H22-1, a pharmacokinetic randomized, double-blinded, cross-over study involving 36 human participants, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands available to U.S. customers, namely ON! and Zyn,” a recent article reads. The human study NIC-H22-1 is expected to build on the successes of the company’s animal studies, which have proven the technology’s effectiveness in promoting faster absorption, higher peak absorption, and greater overall quantities of nicotine, on average, in the blood than concentration-matched control formulations. “In 2021, the company announced its oral nicotine absorption study, NIC-A21-1, revealing that DehydraTECH-oral nicotine delivery peaked in the bloodstream 10x to 20x faster than controls, and peak levels achieved were up to 10x higher than controls. ‘Performance gains of this magnitude could be of great significance in enabling the oral pouch product category to offer improved nicotine satiety and effectiveness, with a goal of one day rendering pulmonary administration practices like smoking and vaping as obsolete,’ Lexaria CEO Chris Bunka said of last year’s outstanding results.”

To view the full article, visit https://cnw.fm/OZuaK

About Lexaria Bioscience Corp.

Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by up to 5-10x, reduce time of onset from 1 – 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Hero Technologies Inc. (HENC) Positioning in 3 of Top 6 US Cannabis Markets

Hero Technologies (OTC: HENC), a cannabis company, is ideally poised as a new report revealed that states that have legalized recreational marijuana collected an estimated $3.7 billion in tax revenue last year. “That news bodes well for savvy players in the legal cannabis space, including Hero Technologies, as states are often eager to support revenue sources,” a recent article reads. “Hero Technologies is looking to leverage its cannabis expertise in more of those states. The company currently has a majority stake in BlackBox Systems and Technologies LLC, which has been operating legally in Michigan as a medical caregiver. HENC is aggressively pursuing an expansion of its cultivation and dispensary operations in Colorado through Mile High Green LLC, a wholly owned subsidiary. The company is also looking to move into Massachusetts through an additional wholly owned subsidiary, MassCannabis LLC. These states are in the top-six cannabis markets in the United States. While California tops the list, Colorado comes in at number three, reporting a $2.5 billion market, with Michigan following in the number four spot, showing a $1.4 billion market. Massachusetts ranks number six, with a market of $1.2 billion.”

To view the full article, visit https://cnw.fm/W13Yh

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. Hero Technologies’ strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information about the company, visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://cnw.fm/HENC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.